1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.

Repligen Corp.

XNAS: RGEN

Momentum Trap
Download real time

128.30 1.60 (1.26%)

29.71% Fall from 52W High

599.5K XNAS Volume

XNAS 06 Jun, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
8S
12W
1O
2T
7,208.3

Market Cap

High in industry
-313.7

PE TTM

Negative PE TTM
1.6

PEG TTM

PEG TTM is much higher than 1
3.6

Price to Book

Below industry Median
0

Beta 1Year

Very Low volatility

Repligen Corp. - RGEN - stock price prediction, stock price target, analyst ratings from 19 analysts

Repligen Corp. has a share price target of US$ 183, revenue growth forecast of 11.8%, and profit growth estimate of 280.9% for FY25, based on top 19 analyst calls.

Forecaster Screeners